#VisualAbstract: Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 100 results for 'stereotactic body radiotherapy '
Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care...
Read More
Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive Breast Cancer or Lung Cancer
1. Progression-free survival in NSCLC was found to be significant with HR 0.41 compared to breast...
Read More
Surgical treatment of esophageal perforation after stereotactic body radiotherapy: A report of two cases.
Esophageal perforation due to stereotactic body radiotherapy (SBRT) is rare, and there is no...
Read More
Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC).
To conduct a cost-effectiveness analysis of stereotactic body radiotherapy (SBRT) versus...
Read More
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
MR-guided daily-adaptive radiotherapy is improving the accuracy in the planning and delivery...
Read MoreEarly-Stage NSCLC: Promising Data for Neoadjuvant Durvalumab with Stereotactic Body Radiotherapy
A recently published phase 2 study in Lancet Oncology showed that the combination of neoadjuvant durvalumab with stereotactic body radiotherapy (SBRT) is safe and grants a nearly 55% major pathologic response rates among...
Read More
To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy-confirmed versus radiologically-diagnosed primary lung cancer in a single Australian institution.
Obtaining tissue diagnosis for lung cancer can sometimes be difficult and unsafe. We evaluated...
Read More
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD).
Stereotactic body radiotherapy (SBRT) has shown promising results in the clinical setting of...
Read MoreAdvertisement
Stereotactic Body Radiotherapy Aids Spinal Metastasis Pain
MONDAY, June 21, 2021 (HealthDay News) — Stereotactic body radiotherapy is superior to...
Read MoreStereotactic Body Radiotherapy Safe for Oligometastatic Patients
Phase I results show safety, no dose-limiting toxicities, but further study needed In cancer...
Read More
Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference.
The concept of a radioresistant (RR) phenotype has been challenged with use of stereotactic body...
Read More
Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases.
Cancer-specific death (CSD) and non-cancer-specific death (non-CSD) after stereotactic body...
Read More
Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
To evaluate feasibility and safety of prostate stereotactic body radiotherapy (SBRT) neoadjuvant...
Read MoreNeoadjuvant stereotactic ablative body radiotherapy combined with surgical treatment for renal cell carcinoma and inferior vena cava tumor thrombus: a prospective pilot study.
Surgical treatment for renal cell carcinoma (RCC) and inferior vena cava (IVC) tumor thrombus (TT) is difficult, and the postoperative complication rate is high. This study aimed to explore the safety and oncologic outcomes of...
Read More
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study.
Stereotactic ablative body radiotherapy (SABR) is increasingly being used to treat oligometastatic...
Read More
Q&A: Chemoradiation With Radiotherapy Improves NSCLC Outcomes
“This technology gives us the ability to be more precise and personalized to each patient,” says Percy Lee, MD.
Read More
Review Offers In-Depth Look at MRI-Guided Radiotherapy in Liver Cancer
Driven by technological advances, MRI-guided radiotherapy has become increasingly important in treating liver cancer.
Read More
Concurrent stereotactic radiation with antibody-drug conjugates in the treatment of brain metastases is associated with a greater risk of symptomatic radiation necrosis
Bookmark1. A greater percentage of patients who received concurrent stereotactic radiation therapy...
Read More
Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases.
External beam radiotherapy is a safe and effective curative treatment modality for men with...
Read More